Synthetic Cannabinoids: An Emerging Cause of Coagulopathy

Synthetic cannabinoids-associated coagulopathy cases are on the rise but are usually undetected in clinical settings due to less awareness among physicians and the lack of available literature on the subject. Patient may also not volunteer information about the use of such substances therefore detai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Shakir, Chaudhary, Amna M., Nawab, Khalid, Athwani, Ravi, Singh, Amandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383497/
https://www.ncbi.nlm.nih.gov/pubmed/34434347
http://dx.doi.org/10.14740/jmc3561
_version_ 1783741750088564736
author Ullah, Shakir
Chaudhary, Amna M.
Nawab, Khalid
Athwani, Ravi
Singh, Amandeep
author_facet Ullah, Shakir
Chaudhary, Amna M.
Nawab, Khalid
Athwani, Ravi
Singh, Amandeep
author_sort Ullah, Shakir
collection PubMed
description Synthetic cannabinoids-associated coagulopathy cases are on the rise but are usually undetected in clinical settings due to less awareness among physicians and the lack of available literature on the subject. Patient may also not volunteer information about the use of such substances therefore detailed history is important. We present a case of a patient found to have coagulopathy of unclear cause as patient did not report the use of synthetic cannabinoid initially.
format Online
Article
Text
id pubmed-8383497
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-83834972021-08-24 Synthetic Cannabinoids: An Emerging Cause of Coagulopathy Ullah, Shakir Chaudhary, Amna M. Nawab, Khalid Athwani, Ravi Singh, Amandeep J Med Cases Case Report Synthetic cannabinoids-associated coagulopathy cases are on the rise but are usually undetected in clinical settings due to less awareness among physicians and the lack of available literature on the subject. Patient may also not volunteer information about the use of such substances therefore detailed history is important. We present a case of a patient found to have coagulopathy of unclear cause as patient did not report the use of synthetic cannabinoid initially. Elmer Press 2020-11 2020-09-23 /pmc/articles/PMC8383497/ /pubmed/34434347 http://dx.doi.org/10.14740/jmc3561 Text en Copyright 2020, Ullah et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ullah, Shakir
Chaudhary, Amna M.
Nawab, Khalid
Athwani, Ravi
Singh, Amandeep
Synthetic Cannabinoids: An Emerging Cause of Coagulopathy
title Synthetic Cannabinoids: An Emerging Cause of Coagulopathy
title_full Synthetic Cannabinoids: An Emerging Cause of Coagulopathy
title_fullStr Synthetic Cannabinoids: An Emerging Cause of Coagulopathy
title_full_unstemmed Synthetic Cannabinoids: An Emerging Cause of Coagulopathy
title_short Synthetic Cannabinoids: An Emerging Cause of Coagulopathy
title_sort synthetic cannabinoids: an emerging cause of coagulopathy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383497/
https://www.ncbi.nlm.nih.gov/pubmed/34434347
http://dx.doi.org/10.14740/jmc3561
work_keys_str_mv AT ullahshakir syntheticcannabinoidsanemergingcauseofcoagulopathy
AT chaudharyamnam syntheticcannabinoidsanemergingcauseofcoagulopathy
AT nawabkhalid syntheticcannabinoidsanemergingcauseofcoagulopathy
AT athwaniravi syntheticcannabinoidsanemergingcauseofcoagulopathy
AT singhamandeep syntheticcannabinoidsanemergingcauseofcoagulopathy

Ejemplares similares